Market Cap: $1.2B
OI
OPKO Health, Inc.
OPK
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.2B
OPKO Health (Ticker: OPK) reinforces its strategic partnership with Nicoya Therapeutics to enhance the commercialization of RAYALDEE, a pharmaceutical product aimed at addressing renal health needs in…
Opko Health's Q4 Earnings Reveal Commitment to Innovative Healthcare Solutions Opko Health, a prominent player in the healthcare sector, reports its Q4 earnings during a conference call held on Februa…
Transformative Innovations Drive OPKO Health’s Performance Amid Market Challenges OPKO Health achieves a noteworthy milestone with its recent quarterly earnings report, demonstrating resilience and po…
Opko Health's Strategic Growth Amidst Industry Challenges Opko Health continues to solidify its position in the healthcare sector with its latest financial results, showcasing a robust performance tha…
Opko Health’s Strong Performance Signals Market Resilience Opko Health stands out in the latest financial reporting season, showcasing significant growth metrics that underscore its robust operational…
Strategic Shift for OPKO Health: Focusing on Core Operations Following Asset Sale In a significant move within the diagnostics industry, OPKO Health, Inc. is poised for a strategic transformation foll…
Strategic Asset Acquisition Enhances Labcorp's Oncology Services On September 15, 2025, Labcorp, a prominent player in laboratory services, announces the acquisition of select assets from BioReference…